Generation Essentials Group, Phio Pharmaceuticals, and Caribou Biosciences are the 3 Penny Stocks to watch on November 4, ...

Find the best penny stocks under $1! Learn about high-growth potential, sales growth, and positive earnings. Discover how to ...

A slowdown in penny circulation, and a presidential halt in minting new ones, is changing how America handles small change.

Beyond Meat’s stock collapsed to near $1 a share on Tuesday after the embattled plant-based meat maker finalized a debt exchange deal that handed bondholders hundreds of millions of new shares — ...

Serabi Gold's tripled in value over the past year, yet still looks undervalued compared to other growth stocks. Mark Hartley investigates. The post Up 226% and still undervalued? Investors can’t get ...

Nvidia continues to be the leader in AI infrastructure. Alphabet is turning into a AI powerhouse. Amazon has become an AI and robotics leader. Artificial intelligence (AI) continues to be the biggest ...

The White House announced a 10% stake in the minerals company The U.S. government continues to spend on its critical minerals supply chain, after the White House announced a deal with minerals ...

Investing in dividend stocks is a great way to get through good and bad times. AbbVie and Coca-Cola both have resilient businesses and strong prospects. They have both increased their dividends for ...

Reddit RDDT and Meta Platforms META are leading social media platforms that monetize user engagement through digital advertising. While RDDT is an emerging social media platform, gaining traction with ...

In a new book, Barbara Masekela, the former South African president’s chief of staff, reveals his yearning to be ordinary, ...

Bank of America Corporation (NYSE:BAC) is one of the best value stocks to invest in now. On September 30, Evercore ISI raised the firm’s price target on Bank of America to $55 from $49, while keeping ...

Eli Lilly and Company (NYSE:LLY) is one of the best growth stocks to buy now. On October 7, Eli Lilly and Company announced new data from the LUCENT-3 Phase 3 open-label extension study demonstrating ...